Avricore Health (AVCRF) Gains from Investment Securities (2018 - 2020)

Avricore Health (AVCRF) reported Gains from Investment Securities of -$4984.3 for Q4 2020, down 232.81% quarter-over-quarter from $3752.9 in Q3 2020.

Avricore Health (AVCRF) Gains from Investment Securities (2018 - 2020) Analysis & Trends

Avricore Health (AVCRF) has 2 years of Gains from Investment Securities data on file, last reported at -$4984.3 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,010.71 Bn	30,010.25 Bn	1.11 Bn
2	Thermo Fisher Scientific	179.46 Bn	176.21 Bn	7.74 Bn
3	Danaher	130.33 Bn	124.64 Bn	3.59 Bn
4	Idexx Laboratories	44.44 Bn	44.24 Bn	722.74 Mn
5	Agilent Technologies	37.27 Bn	35.46 Bn	990.00 Mn
6	Iqvia Holdings	30.70 Bn	28.73 Bn	1.36 Bn
7	Natera	30.59 Bn	29.49 Bn	696.04 Mn
8	Illumina	24.86 Bn	23.71 Bn	721.00 Mn
9	Mettler Toledo International	23.06 Bn	23.00 Bn	555.82 Mn
10	Avricore Health	-	-	-

Download Data